This difference may be the underlying effect of female estrogen receptors and progesterone receptors on the progression of LAM.[43] Considering that LAM in male has mild and atypical symptoms at the onset, this condition tends to be ignored. The gene discussed is ESR1; the disease is lymphangioleiomyomatosis.